Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Rokutanda

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Rheumatology International|February 9, 2025
A feasible treatment strategy for tapering subcutaneous tocilizumab in giant cell arteritis: a 24-month multi-center retrospective studyTakanori Ito, Sho Fukui, Fumika N Nagase, et al.
International Journal of Rheumatic Diseases|December 19, 2025
Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese StudyNobuhiro Oda, Sho Fukui, Fumika N Nagase, et al.
The Journal of Rheumatology|November 15, 2024
Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse EventsFumika N Nagase, Sho Fukui, Naoho Takizawa, et al.
Rheumatology (Oxford, England)|September 28, 2024
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registryYohei Kirino, Ayaka Maeda, Tomoyuki Asano, et al.
The Journal of Rheumatology|February 17, 2019
Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the WorldMitsumasa Kishimoto, Kazuki Yoshida, Naomi Ichikawa, et al.
Modern Rheumatology|October 9, 2025
High Glucocorticoid Dependency and Limited Therapeutic Response in Japanese Patients with VEXAS Syndrome: A Multicentre Retrospective StudyAyaka Maeda, Yohei Kirino, Naomi Tsuchida, et al.
Annals of the Rheumatic Diseases|April 2, 2026
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective studyYohei Kirino, Ayaka Maeda, Kana Higashitani, et al.
Rheumatology (Oxford, England)|August 22, 2023
Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndromeAyaka Maeda, Naomi Tsuchida, Yuri Uchiyama, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Rheumatology International|February 9, 2025
A feasible treatment strategy for tapering subcutaneous tocilizumab in giant cell arteritis: a 24-month multi-center retrospective studyTakanori Ito, Sho Fukui, Fumika N Nagase, et al.
International Journal of Rheumatic Diseases|December 19, 2025
Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese StudyNobuhiro Oda, Sho Fukui, Fumika N Nagase, et al.
The Journal of Rheumatology|November 15, 2024
Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse EventsFumika N Nagase, Sho Fukui, Naoho Takizawa, et al.
Rheumatology (Oxford, England)|September 28, 2024
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registryYohei Kirino, Ayaka Maeda, Tomoyuki Asano, et al.
The Journal of Rheumatology|February 17, 2019
Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the WorldMitsumasa Kishimoto, Kazuki Yoshida, Naomi Ichikawa, et al.
Modern Rheumatology|October 9, 2025
High Glucocorticoid Dependency and Limited Therapeutic Response in Japanese Patients with VEXAS Syndrome: A Multicentre Retrospective StudyAyaka Maeda, Yohei Kirino, Naomi Tsuchida, et al.
Annals of the Rheumatic Diseases|April 2, 2026
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective studyYohei Kirino, Ayaka Maeda, Kana Higashitani, et al.
Rheumatology (Oxford, England)|August 22, 2023
Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndromeAyaka Maeda, Naomi Tsuchida, Yuri Uchiyama, et al.
Pageof 4